Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared a post on LinkedIn:
“The inaugural ACCC Leadership Summit convenes this in two weeks. Senior oncology decision-makers, brought together to help solve problems we are all tackling these days.
I’ll be kicking the meeting off moderating moderating the AI session. Not a theory session. The one where we talk about what’s actually in use, what’s breaking down on implementation, and what cancer program leaders can walk away and do differently on Monday morning.
My panelists include Lucio N. Gordan, MD, who has built one of the most operationally sophisticated community oncology practices in the country.
Ashley Gigandet Joseph knows where AI investments inside health systems pay off – and where they quietly fail. Sanjay Juneja, M.D. is shaping clinical AI at Tempus in ways that are changing real-time oncology decision-making. Debra Patt, MD PhD MBA brings an unrivaled clinical depth, policy fluency, and implementation track record. That combination is harder to find than it should be.
Clinical decision support. Trial matching. Scheduling. Navigation. Workflow. The gap between what we know and what we actually deliver to patients – we’ll be in that gap all morning.
Looking forward to seeing so many of you there.”
Other articles about ACCC on OncoDaily.